title: Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia.
abstract: OBJECTIVE
  To examine the longitudinal course of primary progressive aphasia (PPA) over a 2-year period and to offer quantitative ranges of expected change that could be used to guide the design and evaluation of therapeutic intervention trials.
  
  
  METHODS
  Regional changes of cortical thickness and whole-brain cortical volume loss as well as neuropsychological language performance were assessed at baseline and 2 years later in 13 rigorously characterized patients who fulfilled research criteria for logopenic, agrammatic, and semantic PPA subtypes (6 PPA-L, 3 PPA-G, and 4 PPA-S).
  
  
  RESULTS
  There was substantial progression of clinical deficits and cortical atrophy over 2 years. Neuropsychological language performance patterns lost the sharp distinctions that differentiated one PPA variant from another. Nonetheless, the subtype-specific differential impairment of word comprehension vs grammatical processing was largely maintained. Peak atrophy sites spread beyond the initial distinctive locations that characterized each of the 3 subtypes and displayed a more convergent distribution encompassing all 3 major components of the language network: the inferior frontal gyrus, the temporoparietal junction, and lateral temporal cortex. Despite the progression, overall peak atrophy remained lateralized to the left hemisphere.
  
  
  CONCLUSIONS
  The results suggest that the unique features, which sharply differentiate the PPA variants at the early to middle stages, may lose their distinctiveness as the degeneration becomes more severe. Given the substantial atrophy over 2 years, PPA clinical trials may require fewer patients and shorter study durations than Alzheimer disease trials to detect significant therapeutic effects.
authors: Northwestern University, Cognitive Neurology and Alzheimer's Disease Center (CNADC), 320 E Superior Street, Searle Building 11th Floor, Chicago, IL 60611, USA. erogalski@gmail.com
authors: E
authors: E
authors: Rogalski
authors: D
authors: D
authors: Cobia
authors: T M
authors: TM
authors: Harrison
authors: C
authors: C
authors: Wieneke
authors: S
authors: S
authors: Weintraub
authors: M-M
authors: MM
authors: Mesulam
references: Neuroimage. 2002 Apr;15(4):870-8
references: 11906227
references: Arch Neurol. 1990 Dec;47(12):1329-35
references: 2252450
references: Neuropsychology. 2009 May;23(3):337-46
references: 19413447
references: Neurology. 2011 Mar 15;76(11):1006-14
references: 21325651
references: Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5
references: 10984517
references: Neuroimage. 2006 Jul 1;31(3):968-80
references: 16530430
references: N Engl J Med. 2003 Oct 16;349(16):1535-42
references: 14561797
references: Neurology. 2009 May 26;72(21):1843-9
references: 19470967
references: Handb Clin Neurol. 2008;89:573-87
references: 18631780
references: Neurobiol Aging. 2009 Jan;30(1):103-11
references: 17604879
references: Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S70-8
references: 18090428
references: Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):408-16
references: 19700669
references: Arch Neurol. 2009 Dec;66(12):1545-51
references: 20008661
references: Neuroimage. 2004 Oct;23(2):724-38
references: 15488422
references: Med Image Comput Comput Assist Interv. 2007;10(Pt 2):303-10
references: 18044582
references: Neurology. 2004 Feb 24;62(4):591-600
references: 14981176
references: J Int Neuropsychol Soc. 2007 Mar;13(2):237-45
references: 17286881
references: Ann Neurol. 2004 Mar;55(3):335-46
references: 14991811
references: Ann Neurol. 2008 Jun;63(6):709-19
references: 18412267
references: Neurology. 2010 Jul 27;75(4):358-66
references: 20660866